GC Biopharma wins 59 billion won order
South Korea's GC Biopharma has won a 59 billion won order, Reuters reports. The news concerns one company and has little market impact.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
South Korean biopharmaceutical company GC Biopharma Corp has received an order worth 59 billion won. Reuters reports the win, citing the company's statement. The original report contains no further details.
why it matters
The order is small by market standards, so its effect on the KOSPI index and other assets is likely minimal. The news matters mainly to the company's own shareholders.
tags
instruments
sources
- Gc Biopharma Wins 59 Billion Won Order — Reuters, 2 November 2026 at 02:17 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗